Last reviewed · How we verify
Soft or Connective Tissue Sarcoma
Approved treatments
- Yondelis · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Yondelis · Janssen Prods
Yondelis works by binding to DNA and causing interstrand crosslinks, thereby inhibiting cancer cell growth. - adriacin · Chipscreen Biosciences, Ltd.
- Hydroxydaunorubicin · University of Colorado, Denver
- Liposomal Doxorubicin · Pfizer
- Doxorubicin Hydrochloride · Pfizer
Doxorubicin works by intercalating DNA strands and inhibiting topoisomerase II, an enzyme essential for DNA replication and cell division. - Hydroxydaunomycin · Weill Medical College of Cornell University
- Adriamycin · Johann Wolfgang Goethe University Hospital
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Soft or Connective Tissue Sarcoma patent landscape — cliff calendar, originator estates, attackable patents
- Soft or Connective Tissue Sarcoma treatment landscape brief
- Soft or Connective Tissue Sarcoma treatment updates RSS
Frequently asked questions about Soft or Connective Tissue Sarcoma
What drugs treat Soft or Connective Tissue Sarcoma?
Tracked treatments include Yondelis, adriacin, Hydroxydaunorubicin, Liposomal Doxorubicin, Doxorubicin Hydrochloride, Hydroxydaunomycin, Adriamycin.
What is the treatment for Soft or Connective Tissue Sarcoma?
Standard treatment for Soft or Connective Tissue Sarcoma includes Yondelis, adriacin, Hydroxydaunorubicin, Liposomal Doxorubicin, Doxorubicin Hydrochloride. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Soft or Connective Tissue Sarcoma patent cliff · Soft or Connective Tissue Sarcoma CI report
- Treatment: Yondelis · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Treatment: Yondelis · Janssen Prods
- Treatment: adriacin · Chipscreen Biosciences, Ltd.
- Treatment: Hydroxydaunorubicin · University of Colorado, Denver
- Treatment: Liposomal Doxorubicin · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing